Divergent findings with paclitaxel and nab-paclitaxel in TNBC
Certain patients with triple-negative breast cancer (TNBC) may benefit when atezolizumab is combined with nab-paclitaxel but not with paclitaxel, a pair of phase 3 trials suggest.
Latest News
October 1, 2020
Trump signs Medicare loan relief bill delaying repayments
October 1, 2020
MDedge Hematology and Oncology
October 1, 2020
CRC risk: Raised by meat/alcohol, lowered by aspirin/NSAIDs
October 1, 2020
MDedge Hematology and Oncology
October 1, 2020
The scope of under- and overtreatment in older adults with cancer
October 1, 2020
MDedge Hematology and Oncology
B&C Podcast Shownotes
ESMO 2020: Late-breaking and practice-changing studies
There were a number of practice-changing and ground-breaking studies presented at the ESMO 2020 Virtual Congress, according to our guest in this episode. Alan P. Lyss, MD, subprincipal investigator for Heartland Cancer Research NCORP, joined host David H. Henry, MD, to review highlights from ESMO 2020.
Conference Coverage
September 30, 2020
Neoadjuvant mFOLFIRINOX improves DFS, OS effect uncertain
September 30, 2020
ESMO: European Society for Medical Oncology
MDedge Hematology and Oncology
September 28, 2020
Divergent findings with paclitaxel and nab-paclitaxel in TNBC
September 28, 2020
ESMO: European Society for Medical Oncology
MDedge Hematology and Oncology
September 24, 2020
‘Paradigm shift’ in gastric junction cancers with nivolumab
September 24, 2020
ESMO: European Society for Medical Oncology
MDedge Hematology and Oncology
COVID-19: Heme/Onc
September 20, 2020
Survey quantifies COVID-19’s impact on oncology
September 20, 2020
ESMO: European Society for Medical Oncology
MDedge Hematology and Oncology
September 16, 2020
COVID-19 prompts ‘democratization’ of cancer trials
September 16, 2020
AACR: COVID-19 and Cancer
MDedge Hematology and Oncology
September 16, 2020
COVID-19 and Blood Clots: Inside the Battle to Save Patients
September 16, 2020
MDedge Hematology and Oncology
August 31, 2020
VTE, sepsis risk increased among COVID-19 patients with cancer
August 31, 2020
AACR: COVID-19 and Cancer
MDedge Hematology and Oncology
News from the FDA/CDC
September 9, 2020
Atezolizumab TNBC indication ‘in jeopardy’ because of phase 3 results
September 9, 2020
MDedge Hematology and Oncology
September 8, 2020
Pralsetinib: Second drug for RET+ NSCLC approved in U.S.
September 8, 2020
MDedge Hematology and Oncology
August 31, 2020
FDA expands remdesivir use for all COVID-19 hospitalized patients
August 31, 2020
MDedge Hematology and Oncology
Policy & Practice
October 1, 2020
Trump signs Medicare loan relief bill delaying repayments
October 1, 2020
MDedge Hematology and Oncology
September 29, 2020
Pandemic poses new challenges for rural doctors
September 29, 2020
MDedge Hematology and Oncology
September 28, 2020
Revamping mentorship in medicine
September 28, 2020
MDedge Hematology and Oncology
September 23, 2020
Smart home devices – promises and pitfalls
September 23, 2020
MDedge Hematology and Oncology
Opinion
October 1, 2020
The scope of under- and overtreatment in older adults with cancer
October 1, 2020
MDedge Hematology and Oncology
September 28, 2020
Revamping mentorship in medicine
September 28, 2020
MDedge Hematology and Oncology
September 23, 2020
Smart home devices – promises and pitfalls
September 23, 2020
MDedge Hematology and Oncology
September 21, 2020
Without Ginsburg, judicial threats to the ACA, reproductive rights heighten
September 21, 2020
MDedge Hematology and Oncology